Enlivex Therapeutics shares owned by Renaissance Technologies
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Renaissance Technologies
from 13F filings
Historical chart of Renaissance Technologies investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Renaissance Technologies
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $126k | 75k | 1.68 |
| 2024-06-30 | $102k | 72k | 1.42 |
| 2024-03-31 | $265k | 70k | 3.79 |
| 2023-12-31 | $168k | 62k | 2.71 |
| 2023-09-30 | $93k | 59k | 1.58 |
| 2023-06-30 | $149k | 57k | 2.63 |
| 2023-03-31 | $199k | 55k | 3.64 |
| 2022-12-31 | $213k | 54k | 3.93 |
| 2022-09-30 | $250k | 59k | 4.25 |
| 2022-06-30 | $290k | 64k | 4.52 |
| 2022-03-31 | $356k | 64k | 5.59 |
| 2021-12-31 | $423k | 68k | 6.25 |
| 2021-09-30 | $869k | 88k | 9.88 |
| 2021-06-30 | $1.7M | 196k | 8.90 |
| 2021-03-31 | $3.2M | 290k | 11.09 |
| 2020-12-31 | $2.4M | 279k | 8.43 |
| 2020-09-30 | $1.8M | 299k | 5.94 |
| 2020-06-30 | $1.4M | 272k | 5.06 |
| 2020-03-31 | $445k | 95k | 4.68 |
| 2019-12-31 | $322k | 38k | 8.39 |
| 2019-09-30 | $635k | 24k | 26.69 |
| 2019-06-30 | $428k | 20k | 21.52 |
| 2019-03-31 | $219k | 18k | 12.38 |